Literature DB >> 34921847

Exercise-induced neuroprotection against cerebral ischemia/reperfusion injury is mediated via alleviating inflammasome-induced pyroptosis.

Mei-Xi Liu1, Lu Luo1, Jiang-Hong Fu1, Jie-Ying He2, Meng-Ye Chen1, Zhi-Jie He1, Jie Jia3.   

Abstract

As a primary nonpharmacological tool, exercise training is neuroprotective after experimental ischemic stroke by relieving neuroinflammation. However, the specific mechanism of which and anti-inflammatory effect of exercise at different intensities require in-depth investigations. To explore the issue, middle cerebral artery occlusion-reperfusion (MCAO-r) in mice were utilized, with subsequent exercise training at different intensities (high-intensity interval training versus moderate-intensity continuous training, i.e. HIIT vs. MICT) during an early phase post-modeling. The neurobehavioral assessment showed that MICT improved the performance of neurological deficit scores and rotarod test earlier, while HIIT appeared to be more efficacious to meliorate locomotor impairments and aerobic fitness at the end of intervention. Both exercise regimens inhibited the expressions of NLRP3 inflammasome components (NLRP3, ASC, and Cl.caspase-1) and pyroptosis-associated proteins (GSDMD, Cl.IL-1β, and Cl.IL-18) as indicated by western blot and immunofluorescence co-staining. Multiplex assay panel revealed that both exercise regimens reduced the levels of pro-inflammatory cytokines and upregulated anti-inflammatory cytokine. Furthermore, an increased proportion of M2-like microglia and a diminished proportion of M1-like microglia in the peri-infarct zone were observed by colocalization analysis, which was jointly validated by western blot. Here, for the first time, our study demonstrated that HIIT elicited better improvements at functional and cardiovascular levels than MICT after ischemic stroke, and anti-inflammatory effect of exercise might result from suppression in inflammasome-mediated pyroptosis by shifting microglial polarization toward neuroprotective M2 phenotype.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia; Exercise training; Inflammasome; Microglial polarization; Neuroprotection

Mesh:

Substances:

Year:  2021        PMID: 34921847     DOI: 10.1016/j.expneurol.2021.113952

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

1.  Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NFκB/NLRP3 signaling pathway in cerebral ischemic mice.

Authors:  Lu Luo; Meixi Liu; Yunhui Fan; Jingjun Zhang; Li Liu; Yun Li; Qiqi Zhang; Hongyu Xie; Congyu Jiang; Junfa Wu; Xiao Xiao; Yi Wu
Journal:  J Neuroinflammation       Date:  2022-06-11       Impact factor: 9.587

2.  Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures.

Authors:  Aloia Quijano; Carmen Diaz-Ruiz; Andrea Lopez-Lopez; Begoña Villar-Cheda; Ana Muñoz; Ana I Rodriguez-Perez; Jose L Labandeira-Garcia
Journal:  Antioxidants (Basel)       Date:  2022-02-08

Review 3.  Insight Into the Mechanism of Exercise Preconditioning in Ischemic Stroke.

Authors:  Yuanhan Zhu; Yulin Sun; Jichao Hu; Zhuoer Pan
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

4.  Exercise Intervention Modulates Synaptic Plasticity by Inhibiting Excessive Microglial Activation via Exosomes.

Authors:  Chen Li; Jiayi Hu; Wenhong Liu; Changkai Ke; Chuan Huang; Yifan Bai; Bingchen Pan; Junyi Wang; Chunxiao Wan
Journal:  Front Cell Neurosci       Date:  2022-07-19       Impact factor: 6.147

5.  Exercise Preconditioning Ameliorates Cognitive Impairment in Mice with Ischemic Stroke by Alleviating Inflammation and Modulating Gut Microbiota.

Authors:  Heng Lv; Shasha Wang; Meihui Tian; Liya Wang; Jie Gao; Qitao Zhao; Zhaoyu Li; Xianjie Jia; Ying Yu
Journal:  Mediators Inflamm       Date:  2022-10-10       Impact factor: 4.529

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.